The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 05, 2016
Filed:
Sep. 26, 2013
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Kevin J. Wilson, Boston, MA (US);
David J. Witter, Norfolk, MA (US);
Matthew H. Daniels, Somerville, MA (US);
Angie R. Angeles, Boston, MA (US);
Phieng Siliphaivanh, Newton, MA (US);
David Sloman, Brookline, MA (US);
Brendan O'Boyle, Pittsburgh, PA (US);
Danielle Falcone, Brookline, MA (US);
Catherine White, Newton Center, MA (US);
Ron Ferguson, Scotch Plains, NJ (US);
Wei Zhou, Scotch Plains, NJ (US);
Kathryn Lipford, Boston, MA (US);
Umar Faruk Mansoor, Framingham, MA (US);
Salem Fevrier, Cranford, NJ (US);
Xianhai Huang, Warren, NJ (US);
Ravi Kurukulasuriya, Niantic, CT (US);
Judson E. Richard, Kittery, ME (US);
Shuyi Tang, Belmont, MA (US);
Christopher Boyce, Flemington, NJ (US);
Joseph Kozlowski, Princeton, NJ (US);
Raman Kumar Bakshi, Bangalore, IN;
Ganesh Babu Karunakaran, Bangalore, IN;
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Abstract
Disclosed are the ERK inhibitors of formula (1.0), having a pyrazolopyridine base structure, and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1.0).